13F-HR filed by BRAIDWELL LP
BRAIDWELL LP filed this 13F-HR for the quarter ended 2024-09-30, filed 2024-11-14, with 81 holding rows worth $3,527,985,574.
- Accession
- 0001920938-24-000006
- Filer
- CIK 1920938
- Filed
- 2024-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2024
A holdings report, 81 entries on the cover page, a total value of $3,527,985,574 stated on the cover page (in dollars after the unit check, H1), rows summing to $3,527,985,574 with VALUE read as dollars as filed, 13F file number 028-23075. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| GUARDANT HEALTH INC | 40131MAB5 | NOTE 11/1 | 268,252,000 | $215,984,055 | dollars as filed | principal |
| BRIDGEBIO PHARMA INC | 10806XAB8 | NOTE 2.500% 3/1 | 140,838,000 | $145,613,126 | dollars as filed | principal |
| NOVOCURE LTD | 67011XAB9 | NOTE 11/0 | 140,834,000 | $133,257,156 | dollars as filed | principal |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 3,170,875 | $119,637,114 | dollars as filed | |
| NUVASIVE INC | 670704AJ4 | NOTE 0.375% 3/1 | 114,206,000 | $111,855,357 | dollars as filed | principal |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 2,707,255 | $106,584,629 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 917,674 | $105,734,398 | dollars as filed | |
| NEOGENOMICS INC | 64049MAB6 | NOTE 0.250% 1/1 | 116,381,000 | $96,887,183 | dollars as filed | principal |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 1,643,226 | $96,523,095 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 3,125,183 | $90,130,278 | dollars as filed | |
| IRONWOOD PHARMACEUTICALS INC | 46333XAH1 | NOTE 1.500% 6/1 | 92,740,000 | $82,465,204 | dollars as filed | principal |
| DEXCOM INC | 252131AM9 | NOTE 0.375% 5/1 | 92,700,000 | $82,271,250 | dollars as filed | principal |
| ALIGN TECHNOLOGY INC COM | 016255101 | Stock | 311,679 | $79,266,203 | dollars as filed | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 3,342,124 | $76,668,325 | dollars as filed | |
| INSULET CORP | 45784PAK7 | NOTE 0.375% 9/0 | 63,800,000 | $76,384,550 | dollars as filed | principal |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 1,541,551 | $75,119,780 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 1,156,977 | $73,248,214 | dollars as filed | |
| KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A | G52694109 | Stock | 2,894,513 | $72,333,880 | dollars as filed | |
| PENUMBRA INC COM | 70975L107 | Stock | 361,428 | $70,229,075 | dollars as filed | |
| DEXCOM INC | 252131AK3 | NOTE 0.250%11/1 | 73,500,000 | $70,137,375 | dollars as filed | principal |
| MARAVAI LIFESCIENCES HLDGS A | 56600D107 | COMMON STOCK | 8,353,287 | $69,415,815 | dollars as filed | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 4,873,853 | $67,892,772 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 2,189,836 | $64,403,077 | dollars as filed | |
| REPLIGEN CORP COM | 759916109 | Stock | 396,781 | $59,048,948 | dollars as filed | |
| IRHYTHM HOLDINGS INC COM | 450056106 | Stock | 782,557 | $58,097,032 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 761299AB2 | NOTE 2.500% 9/1 | 56,031,000 | $53,537,621 | dollars as filed | principal |
| ALPHATEC HLDGS INC | 02081GAB8 | NOTE 0.750% 8/0 | 58,217,000 | $52,510,820 | dollars as filed | principal |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 96,724 | $52,432,146 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 1,958,310 | $52,267,294 | dollars as filed | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 238,911 | $50,422,167 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 370,400 | $46,259,256 | dollars as filed | |
| Bridgebio Pharma Inc Note 2.250 percent 2/0 | 10806XAD4 | Convertible | 53,594,000 | $45,018,960 | dollars as filed | principal |
| Intuitive Surgical,Inc. | 46120E602 | COM | 91,300 | $44,852,951 | dollars as filed | |
| AVADEL PHARMACEUTICALS PLC | G29687103 | COM SHS | 3,388,939 | $44,445,935 | dollars as filed | |
| BICARA THERAPEUTICS INC | 055477103 | COM | 1,657,600 | $42,219,072 | dollars as filed | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 707,240 | $41,069,427 | dollars as filed | |
| GLAUKOS CORP COM | 377322102 | Stock | 311,616 | $40,597,332 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 183,818 | $39,009,856 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 297,568 | $34,003,095 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 3,070,837 | $33,656,374 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 1,284,472 | $31,636,545 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 168,691 | $30,706,823 | dollars as filed | |
| ORTHOPEDIATRICS CORP | 68752L100 | COMMON STOCK | 1,107,770 | $30,031,645 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 441,086 | $29,570,405 | dollars as filed | |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 247,750 | $29,425,268 | dollars as filed | |
| PARAGON 28 INC | 69913P105 | COM | 4,135,109 | $27,622,528 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 3,499,427 | $24,775,943 | dollars as filed | |
| ALPHATEC HLDGS INC | 02081G201 | COM NEW | 4,041,065 | $22,468,321 | dollars as filed | |
| HARROW INC | 415858109 | COM | 439,638 | $19,766,124 | dollars as filed | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 1,176,173 | $19,689,136 | dollars as filed | |
| AMPHASTAR PHARMACEUTICALS IN | 03209RAB9 | NOTE 2.000% 3/1 | 18,400,000 | $19,521,212 | dollars as filed | principal |
| EXACT SCIENCES CORP COM | 30063P105 | Stock | 286,178 | $19,494,445 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 2,239,770 | $19,485,999 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 1,647,565 | $18,798,717 | dollars as filed | |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 4,438,232 | $18,285,516 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 189,200 | $15,854,960 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 493,687 | $13,517,150 | dollars as filed | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 1,225,448 | $13,247,093 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 884,306 | $13,185,002 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 515,726 | $12,640,444 | dollars as filed | |
| HAEMONETICS CORP MASS | 405024AB6 | NOTE 3/0 | 11,500,000 | $10,637,500 | dollars as filed | principal |
| ALECTOR INC | 014442107 | COMMON STOCK | 2,158,245 | $10,057,422 | dollars as filed | |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 2,472,806 | $10,039,592 | dollars as filed | |
| INSULET CORP COM | 45784P101 | Stock | 42,500 | $9,891,875 | dollars as filed | |
| NEVRO CORP | 64157F103 | COM | 1,698,768 | $9,496,113 | dollars as filed | |
| CASTLE BIOSCIENCES INC | 14843C105 | COMMON STOCK | 331,986 | $9,468,241 | dollars as filed | |
| XENCOR INC | 98401F105 | COMMON STOCK | 466,448 | $9,380,269 | dollars as filed | |
| JASPER THERAPEUTICS INC | 471871202 | COM NEW | 483,300 | $9,090,873 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 298,400 | $7,597,264 | dollars as filed | |
| LEXEO THERAPEUTICS INC | 52886X107 | COMMON STOCK | 728,777 | $6,588,144 | dollars as filed | |
| PULMONX CORP | 745848101 | COM | 752,541 | $6,238,565 | dollars as filed | |
| SKINHEALTH SYSTEMS INC | 88331L108 | COM CL A | 4,049,694 | $5,831,559 | dollars as filed | |
| CUTERA INC | 232109AG3 | NOTE 4.000% 6/0 | 29,000,000 | $4,976,413 | dollars as filed | principal |
| CUTERA INC | 232109AD0 | NOTE 2.250% 6/0 | 25,240,000 | $4,038,410 | dollars as filed | principal |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 1,069,158 | $3,816,894 | dollars as filed | |
| VERVE THERAPEUTICS INC | 92539P101 | COM | 623,980 | $3,020,063 | dollars as filed | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 217,928 | $2,046,344 | dollars as filed | |
| HILLEVAX INC | 43157M102 | COM | 1,064,000 | $1,872,640 | dollars as filed | |
| LEXICON PHARMACEUTICALS INC | 528872302 | COMMON STOCK | 801,584 | $1,258,487 | dollars as filed | |
| DBV TECHNOLOGIES S A | 23306J200 | ADR | 1,630,542 | $1,141,379 | dollars as filed | |
| ELEVATION ONCOLOGY INC COM | 28623U101 | Stock | 473,503 | $284,054 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001920938-24-000006 | this filing | 2024-11-14 | acceptance time not in the bulk data set |